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Abstract
Rationale To improve the quality of exercise-based cardiac
rehabilitation (CR) in patients with chronic heart failure
(CHF) a practice guideline from the Dutch Royal Society for
Physiotherapy (KNGF) has been developed.
Guideline development A systematic literature search was
performed to formulate conclusions on the efficacy of
exercise-based intervention during all CR phases in
patients with CHF. Evidence was graded (1–4) accord-
ing the Dutch evidence-based guideline development
criteria.
Clinical and research recommendations Recommendations
for exercise-based CR were formulated covering the
following topics: mobilisation and treatment of pulmo-
nary symptoms (if necessary) during the clinical phase,
aerobic exercise, strength training (inspiratory muscle
training and peripheral muscle training) and relaxation
therapy during the outpatient CR phase, and adoption
and monitoring training after outpatient CR.
Applicability and implementation issues This guideline pro-
vides the physiotherapist with an evidence-based instrument
to assist in clinical decision-making regarding patients with
CHF. The implementation of the guideline in clinical practice
needs further evaluation.
Conclusion This guideline outlines best practice standards for
physiotherapists concerning exercise-based CR in CHF pa-
tients. Research is needed on strategies to improve monitoring
and follow-up of the maintenance of a physical active lifestyle
after supervised CR.
Keywords Chronic heart failure . Exercise-based .
Guideline . Clinical practice
Rationale
Chronic heart failure (CHF) is defined as ‘a complex of
signs and symptoms associated with a structural or
functional abnormality of the heart’. [1] CHF involves
peripheral and central changes, which are functional (as
a compensation mechanism) in the short term, but have
adverse consequences in the long term, resulting in
reduced exercise capacity. The most frequent causes of
CHF are hypertension and coronary artery disease; less
frequent causes include heart valve diseases, arrhythmias
and viral infections. The prevalence and incidence of
CHF increases with age, and has an adverse overall
prognosis with a 5-year mortality rate of 45 %. In
2012, 4136 women and 2625 men died as a conse-
quence of CHF in the Netherlands [2].
Multidisciplinary cardiac rehabilitation (CR) reduces
mortality and early hospital readmission, progressive
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deterioration of CHF and prevents recurrence of cardiac
events. [3, 4] Exercise training, usually conducted by
physiotherapists, constitutes an important part of CR
aiming to improve exercise capacity and quality of life
(QoL) both in the short and long term. The mechanisms
underlying these beneficial effects involve improvement
of muscle perfusion, muscle metabolism, ventilatory ef-
ficiency, neurohormonal regulation and cardiac function
[4–6].
The exact content of exercise-based CR programs in
CHF patients in the Netherlands is not well established.
Within Dutch CR centres, there is considerable variation
in the methods for determination of exercise intensity
training, training intensity and volume. [7] A possible
explanation is that guidelines and position statements
lack clear practical guidance for physiotherapists.
[8–14] Therefore, a clinical practice guideline on
exercise-based CR was developed by the Dutch Royal
Society for Physiotherapy (KNGF), describing optimal
exercise-based CR, including assessment, treatment and
evaluation in CHF patients. This clinical practical guide-
line and the guideline for exercise-based CR in patients
with coronary artery disease [15] can be considered as a
supplement to the Dutch Multidisciplinary Guideline for
CR [9].
Guideline development process
This guideline has been systematically developed according to
the method of Physiotherapy Development in the
Netherlands, [16] which is in line with international methods
of guideline development [17].
A computerised literature search was undertaken in the
Cochrane library, Medline, PEDro-database, Cinahl and rele-
vant available national and international guidelines of CR,
[8–14, 18] using the following key words (in Dutch and
English): heart disease, chronic heart failure, systolic heart
failure, congestive heart failure, treatment outcome, diagnosis,
exercise, and physiotherapy.
Recommendations for exercise-based CR were, if
they existed, based on systematic reviews or meta-anal-
yses, and if available completed with more recent
randomised-controlled trials (RCTs) and otherwise based
on RCTs only. Methodological quality of RCTs was
scored using the physiotherapy evidence database
(PEDro) scale. [19] Only studies with a score of more
than 5 out of 10 points were included. If there was
insufficient scientific evidence, recommendations were
based on consensus within the guideline development
group (GDG).
The level of evidencewas categorised on the basis of Dutch
national agreements on evidence grading for guideline devel-
opment (EBRO/CBO) (Table 1).
Comments, modification and financing
The guideline is written by the GDG, consisting of the
following disciplines: physiotherapists representing the
KNGF, movement scientists, epidemiologists, a repre-
sentative of the Dutch multidisciplinary CR guideline
committee and a cardiologist representing the CR sec-
tion of the Dutch Society of Cardiology. An external
group, consisting of a clinical exercise physiologist, a
physician, and two physiotherapists, reviewed the draft
versions of the guideline. The members of the guideline
GDG and the external members have declared that they
have no conflict of interest. This study was funded by
the KNGF.
Clinical and research recommendations
The CR process is divided into the following phases:
& Clinical phase (phase I)
& Outpatient CR phase (phase II)
& Post-CR phase (Phase III)
This guideline focuses mainly on the outpatient CR phase
(phase II).
Table 1 Levels of scientific evidence
Level of evidence Quality levels (intervention
and prevention)
Level 1: study at A1 level or at least
two independent A2 level studies
A1 Systematic review of at least
two independent A2 level
studies
A2 Randomised, double-blind,
comparative clinical trial of good
quality and sufficient sample
size
Level 2: one study at A2 level or at
least two independent B level
studies
B Comparative study not meeting
all criteria mentioned under A2
(including case-control studies
and cohort studies)
Level 3: one B or C level study C Non-comparative study
Level 4: expert opiniona D Opinions of experts, for instance
the members of the guideline
development team
aAdditionally, other aspects were used to determine recommendations in
this case, such as clinical relevance, safety, patient and professional
perspective, availability of devices and resources, health organisations,
and ethnical and organisational aspects
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Clinical phase (phase I)
It should be noticed that the majority of patients with CHF are
referred to CR straight from the outpatient setting, without
recent clinical admission. This subset includes stable patients
who remain symptomatic despite optimal medical and device
therapy.
Recommendation 1. Stay at intensive care unit (ICU)
or coronary care unit (CCU) and mobilisation
during the clinical phase (phase I)
Relative rest is recommended during the patients’ stay at the
CCU after an acute cardiac event or after their stay at the ICU
following heart surgery. Dynamic mobilisation exercises and
treatment of pulmonary symptoms (if necessary) results in
a faster recovery and a better physical health at dis-
charge in CHF patients undergoing revascularisation
surgery [20, 21] (level 1), valve replacement and (left)
ventricular surgery, and after decompensation or other
cardiac events (level 4).
Postoperative pulmonary complications (such as ob-
structive pulmonary diseases) are treated if necessary (as
indicated by the pulmonologist or other medical special-
ist) at the CCU or ICU. Perioperative treatment involves
teaching the patient techniques to improve ventilation
and to mobilise and cough up sputum (breathing,
huffing and coughing techniques) and advising the
patient.
The clinical mobilisation should include functional
exercises, such as exercises related to activities of daily
living (ADL) and walking at an early stage of this
phase. Exercise should be discontinued or intensity
should be decreased if patients show signs of excessive
strain/cardiac overload. The physiotherapist explains the
aetiology and/or the treatment (e.g. medication, surgery),
ways of coping with CHF and other complaints during
daily life (i.e. how to ‘respond to the demands of life’,
and how to recognise signs of excessive strain), and
how to gradually increase the intensity of activities at
home. Table 2 lists the referral information provided
before the mobilisation starts, signs of excessive strain/
cardiac overload and outcome criteria.
Outpatient CR phase (phase II)
Patients with CHF will be referred to the CR team by their
cardiologist when they have returned to a stable state (in terms
of filling volume, medication use and functional classifica-
tion) after a clinical admission or after a routine outpa-
tient check-up. The outpatient CR consists of an intake /
assessment procedure, a treatment phase and an
evaluation, which will be discussed chronologically in
the following sections.
Intake / assessment procedure
At the start of the outpatient CR phase, all eligible patients
should be referred for an intake procedure, carried out by a
member of the CR team, in many cases the CR coordinator/
nurse, preferably by using a clinical algorithm for patient
needs in CR (Fig. 1) [22].
Based on the results of the assessment procedure, the CR
coordinator/nurse, in consultation with the patient, decides
what type of care or what interventions are indicated. The
patient then goes through a specific assessment for each of the
relevant disciplines, after which they start one or more CR
programs (Fig. 1.).
If the patient has no contraindications for physical
training (Table 3), an additional assessment should be
performed by the physiotherapist to define the content
of the training program.
The aim of the physiotherapist’s assessment is to
assess the nature and severity of patients’ health prob-
lems in relation to their physical functioning (in terms
of movements) and to assess the extent to which this
can be modified. Fig. 2 shows a flowchart of the as-
sessment procedure.
The assessment focuses on identifying impairments of
bodily functions, limitations of activities, restrictions of
participation and health problems that may influence the
choice of exercise activities to be included in the train-
ing program. Limitations of activities may regard their
nature, duration and/or quality. The physiotherapist anal-
yses the performance of problematic activities that were
identified using the patient-specific complaints instru-
ment. [23] The physiotherapist assesses the quality of
the patient’s aspects of physical performance (including
endurance, strength, speed, agility and coordination) and
the degree to which the patient is able to use them. The
physical performance during activities perceived as
problematical can be scored in terms of duration and
intensity, perceived fatigue (Borg Rating of Perceived
Exertion (RPE) scale 6–20) [24] and in terms of anxi-
ety, chest pain and dyspnoea (Borg 1–10). If requested
by the patient’s physician, the physiotherapist can mon-
itor the patient’s heart rate and blood pressure during
these activities. The modified Shuttle Walk Test (SWT)
[25–27] is used to determine patients’ functional exer-
cise capacity. The MET method and the Specific
Activity Scale (SAS) [28] can be used to estimate
whether any discrepancy between the actual perfor-
mance level and the target level can be eliminated with
a suitable training program. The physiotherapist
8 Neth Heart J (2015) 23:6–17
measures patients’ maximum inspiratory pressure
(Pimax) using a Pimax meter. Based on the results of
the assessment procedure, rehabilitation goals will be
defined.
Treatment phase
The treatment during the outpatient CR phase comprises three
modalities: information/advice, a tailored training program
and a relaxation program (Fig. 3). The physiotherapist sys-
tematically evaluates the rehabilitation goals, during and at the
end of the treatment. Typically, the treatment phase should last
for a period 8 to 12 weeks in order to obtain the optimal
treatment result.
Information / advice
Information and advice must be given in a multidisciplinary
context. The physiotherapist offers the patient assistance
(guidance, coaching), information and advice, geared towards
their personal goals. Patient education about the disorder and
the importance of treatment are required to enable the patient
to cope effectively with CHF.
Aims of information and advice may include:
Table 2 Referral information and reasons to terminate training during mobilisation, and final outcome criteria (phase I)
Referral information Reasons to terminate training Outcome criteriaa
Reason for referral Angina Able to function at a sufficient ADL level (including e.g.
walking and self-care, with assistance if necessary)
Date of hospital admission Impaired pump function (shortness of breath
disproportionate to exertion, abnormal fatigue
disproportionate to exertion, increased
peripheral / central oedema)
At least some knowledge of their CHF, and if applicable
about the treatment such as surgery (sternotomy,
wound recovery etc.)
Diagnosis Arrhythmias (high heart rate not in proportion to
exertion, irregular heartbeat, changes in
known arrhythmias)
The patient knows how to cope with their CHF
symptoms and is able to increase exercise intensity
and expand their ADL activities
Date of event or treatment Abnormal increase or decrease of blood pressure
Medication use (type and dosage regime) Fainting
Complications and/ or comorbidities Dizziness
Further diagnostic information deemed
relevant by the cardiologist
Vegetative reactions (excessive perspiring, pallor)
ADL activities of daily living, CHF chronic heart failure
a In some exceptional cases, patients may not have met these goals at the time of discharge from hospital, due to psychosomatic, social or severe physical
problems (e.g. comorbidities). These patients may be referred for clinical admission to a specialised multidisciplinary CR centre for more intensive care
Fig. 1 Flowchart of multidisciplinary cardiac rehabilitation screening
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– Improving patients’ understanding of their disorder, CR
and illness beliefs;
– Education on a healthy active lifestyle;
– Recognising signs of deterioration (decompensation) of
the CHF;
– Promoting compliance;
– Promoting effective ways of dealing with symptoms and
exertion in daily life (level of dyspnoea and fatigue);
– Promoting return to work / occupational activities (where
applicable, most patients are past retirement age).
Tailored training program
The training program is intended for patients who are:
& Referred by a cardiologist and have no contraindications
for training (Table 3);
& Functionally stable (i.e. no change in NYHA class) and on
optimal medication for at least 3 weeks;
& NYHA Class II or III;
Table 3 Contraindications for training, signs of excessive strain and safety criteria (phase II)
Contraindications Excessive strain Safety criteria
• Progressive increase in heart
failure symptoms
• Severe fatigue or dyspnoea out of
proportion to the level of exertion
• ICD
Cardiologist informs physiotherapist
about safe heart rate range
First 6–8 weeks after implantation
no (submaximal) strength training
of the upper extremitiesa
• Severe ischaemia of the cardiac
muscle upon exertion
• Angina
• Respiratory frequency of more
than 30 breaths per minute
• Unexpected increase in breathing rate
(>40 breaths per minute)
• Dyspnoea while speaking • Pulse pressure reduction (≥10 mmHg) • Diabetes mellitus
Check for wounds and sensory
defects (monofilament test)
Check blood glucose values
before, during and after the exercise
session. Blood glucose values ≤5
and ≥15 mmol/L
are relative contraindications for
exercising
Retinopathy of grade ≥3 is a relative
contraindication for training
• Heart rate at rest >110 bpm • Reduction of systolic blood pressure
during exercise (>10 mmHg)
• Peak VO2<10 mL/kg/min • Increasing ventricular or
supraventricular arrhythmias
• Ventricular tachycardia upon
increasing exertion
• Vegetative reactions such as
dizziness or nausea
• Poorly controlled diabetes mellitus
(in consultation with patient’s
internal medicine specialist)
• Pulmonary problems
No desaturation; this usually means
that O2 saturation (SaO2) should
remain ≥90 % during exercising
(and should not fall by ≥4 %)+
• Fever
• Acute systemic diseases
• Recent pulmonary embolism
(<3 months ago) causing
severe haemodynamic strain
• Thrombophlebitis
• Acute pericarditis or myocarditis
• Haemodynamically serious aortic
stenosis or mitral valve stenosis
• Heart valve failure constituting an
indication for surgical intervention
• Myocardial infarction less than 3
weeks before the start of the training
• Atrial fibrillation with rapid ventricular
response at rest (>100 bpm)
• Serious cognitive problems (memory,
attention and concentration)
• Weight gain of >3 kg within a few
days, whether or not accompanied
by increased dyspnoea at rest
a Symmetrical functional movements below the patient’s pain threshold (with comfortable rather than forceful movements and controlled breathing) can
be started within 6 weeks after surgery (which can also help to prevent the development of a frozen shoulder)
+ The physiotherapist should consult the patient’s pulmonologist or cardiologist to decide on the minimum individual saturation value
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Based on the individual goals, patients’ preferences and
limitations established during the assessment procedure in
combination with results of the maximum or symptom-
limited exercise test with respiratory gas analysis and safety
criteria (Table 3), a definite training program is composed. It is
important to realise that a substantial number of CHF patients
do not respond to training in terms of an increase in VO2 peak
[29, 30].
The physiotherapist observes the patient’s training
intensity, individual response, tolerance of the exercise
load and their overall clinical status. Also the patient’s
response during the recovery phase after exercise is
monitored. The exercise session must be terminated
when safety criteria are exceeded, or if there are any
reasons for excessive strain (Table 3).
During the first 2–4 weeks of the training program,
the physiotherapist systematically measures the patient’s
blood pressure and heart rate (and rhythm) before, dur-
ing and after the training session. This supervised peri-
od is extended if any arrhythmias, ischaemia, angina,
blood pressure abnormalities or supraventricular or ven-
tricular ectopy occur during exercising. Patients with
documented ischaemia or arrhythmias may need to have
their cardiac rhythm monitored by ECG, if indicated by
their cardiologist. In the case of comorbidities, the GDG
recommends starting the training program, based on the
exercise principles, relating to the exercise limiting fac-
tor, and/ or the most restrictive pathology or disorder. A
low-intensity start is recommended in case of doubt.
The tailored training program may comprise practising
skills and activities (to enable patients to utilise their general
or strength endurance in motor activities), aerobic interval/
endurance training, strength endurance training (inspiratory
muscle training and peripheral muscle training), practising
functions/activities, and/or (aerobic) training to reduce cardio-
vascular risk factors (if atherosclerosis is the underlying case
of CHF).
Recommendation 2. Aerobic endurance and/or interval
training
Aerobic endurance or interval training increases the exercise
capacity and QoL in patients with CHF (NYHA Classes II-III)
and is therefore recommended. The mechanisms underlying
these beneficial effects involve improvement of patients’muscle
perfusion, muscle metabolism, breathing efficiency, neurohor-
monal regulation and cardiac pump function (Level 1) [4–6].
It is assumed that high-intensity interval training (HIT)
results in a better improvement of left ventricular function
than moderate-intensity training (Level 2) [31].
HIT may result in a greater improvement of the aerobic
endurance capacity than moderate-intensity training (Level 2)
[32].
The research concerning the effectiveness of HIT training
is conducted in relatively low-risk CHF patients; therefore the
GDG advises to be cautious in patients with a high risk of
cardiac overload (Level 4). If HIT is applied, the cardiologist
should be informed and safety criteria (Table 3) should be
closely adhered to.
Training should be individually directed and functionally
geared toward personal goals. If the goal is to improve endur-
ance capacity, aerobic exercise can be gradually increased
from 50 to 80 % of VO2 peak/ heart rate reserve, preceded
by warming up and followed by cooling down. HIT can
involve interval blocks of 4 times 4 min at 80–90 % of VO2
peak / heart rate reserve, with active recovery for 3 min at 40–
50 % of VO2 peak / heart rate reserve (as determined by the
maximum or symptom-limited exercise test with respiratory
Fig. 2 Flowchart of the assessment procedure performed by the physiotherapist
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gas analysis). During both endurance or interval training and
HIT, the program should preferably start with a 2-week intro-
ductory period in which the patient trains at an intensity of 40–
50 % of VO2 peak / heart rate reserve. Patients with a VO2
peak >10.5 mL/kg/min, but <17.5 mL/kg/min (3–5METs/40–
80 W) appear to benefit most from 1 to 2 training sessions a
Fig. 3 Flowchart of the physiotherapy process
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day for 15 min, focusing on aerobic interval training. Patients
with a VO2 peak >17.5 mL/kg/min (≥5 METs / ≥80 W) can
limit their training to 2–3 sessions a week, for 20–30 min per
training session [9].
If the goal is to improve patients’ endurance capacity,
training intensity should be based on the results of a
maximum or symptom-limited exercise test with respi-
ratory gas analysis (Table 4), preferably on a percentage
of VO2 peak, VO2 reserve (the difference between the
VO2 max and the VO2 at rest) or the ventilatory or
anaerobic threshold, converted into heart rate (or work
rate, Watt). If no respiratory gas analysis has been done,
the maximum heart rate attained can be used to calcu-
late the training zone. In both cases, the Karvonen
formula is used to calculate the training heart rate as a
percentage of the heart rate reserve, added to the resting
heart rate. [33] If the patient’s heart rate does not rise
sufficiently during the maximum or symptom-limited
exercise test with respiratory gas analysis, the training
intensity should be based on a percentage of the max-
imum capacity expressed in Power (Watt) or METs,
and/or the Borg score (6–20).
Recommendation 3. Submaximal strength training
Strength training increases muscle strength and endur-
ance, and is recommended in preparation for, or as an
adjunct to, aerobic exercise training for patients with
stable CHF (Level 1) [5, 34].
This type of exercise training is particularly suitable for
patients who experience strength-related limitations in activi-
ties of daily living and during social participation. The GDG
advises caution with strength training in the CHF patient
(research has only been conducted in relatively low-risk
CHF patients), especially in patients with a left ventricular
function <35 % (Level 4).
Strength training should be functional and directed
toward personal goals and individual restrictions in
daily life. The strength training starts with a 2-week
‘pre-training’ period, involving 2–3 series of 10 repe-
titions against a low resistance estimated at <30 % of 1
repetition maximum (RM). After this pre-training peri-
od, the resistance level for strength training can be
estimated on the basis of 10 RM. If the goal is to
improve the patient’s muscle strength, the external re-
sistance can be gradually raised from 40 to 65 % of
the 1RM. Training the large muscle groups is recom-
mended, at a frequency of 2–3 times a week, in 10–15
repetitions of 2–3 series.
Recommendation 4. Inspiratory muscle training (IMT)
IMT increases Pimax and reduces the sensation of
dyspnoea and is therefore recommended in CHF pa-
tients with a Pimax <70 %predicted (Level 2) [35–37]
or a ventilatory impairment according to the maximum
or symptom-limited exercise test with respiratory gas
analysis (i.e. insufficient or absent breathing reserve)
(Level 4).
Table 4 Information to determine training intensity
• The patient’s current physical condition, based on the maximum
or symptom-limited exercise test with gas analysis (spiro-ergometry)
• Protocol used
• The referring physician’s evaluation of the electrocardiogram before,
during and after exercise (criteria for cardiac ischaemia, arrhythmias
and the practical consequences of the findings)
• Heart rate at rest, the maximum heart rate and recovery heart rate
(especially during the first minute)
• Maximum VO2max and wattage achieved (and the percentage of the
predicted value)
• Blood pressure changes at rest, during exercise and during the recovery
phase
• The reason for terminating the test and the level of the impairment
(central or peripheral)
• Medication use (type and dosage)
• The patient’s subjective symptoms during the test (angina/ dyspnoea)
and his/her Borg score
• Spiro-ergometry: gas exchange parameters such as maximum oxygen
uptake (VO2max), the percentage of predicted VO2max, O2 pulse,
maximum respiratory minute volume (VE) (tidal volume and
respiratory rate), respiratory exchange rate, anaerobic or ventilatory
threshold, VE/VCO2 ratio, saturation and any other relevant
parameters (e.g. VO2 oxygen uptake efficiency slope and the presence
of respiratory oscillations)
• The maximum voluntary ventilation, which may be derived (37.5× the
forced expiratory volume (FEV1))
Table 5 Situations that may prevail in the final evaluation at the conclu-
sion of the CR programa
• The patient has attained his/her goals at an optimum level
• The patient has partially attained his/her goals, and it seems likely that
he/she will be able to continue the training activities elsewhere, under
supervision, and thus eventually attain these goals
• The patient has not attained his/her goals and it seems likely that he/she
has attained their maximum achievable level. Not all patients will
improve their endurance capacity and therefore need for example to
spread their energy expenditure and to deal with their dyspnoea in a
functional way
aAfter the outpatient CR phase, all patients with CHF are referred to after-
care activities (Phase III); in exceptional cases they may be referred to a
specialised CR centre for clinical rehabilitation
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High-intensity IMT may produce better results than low-
intensity IMT, however in practice the high load training is not
suitable for patients with dyspnoea during low ADL effort
(Level 4).
Low-intensity IMT should be performed against a resis-
tance of 20–40 % of Pimax for 30 min/day or 2 times 15 min/
day, on 3–4 days a week, preferably for a period of 8–12
consecutive weeks, and high-intensity IMT against a
Table 6 Evaluation and screening instruments for each goal in physical therapy
Goal Evaluation instrument When Final outcome
Specific physical goals
I. Optimising
exercise capacity
By physician
• Maximum or symptom-limited exercise
test with gas analysis plus Borg RPE scale
(6–20), and as desired scoring Anxiety,
Angina and/or Dyspnoea
At start and end of CR
and / or training program
Exercise capacity is at optimum
or target level for this patient
By cardiac rehabilitation coordinator
• Subjective physical score on KVL-H
questionnaire
By physiotherapist
• As for goals one and two
• (modified) SWT
• Possibly MET method and/or SAS
At start, every 4 weeks and at end
of CR and/ or training program
Functional exercise capacity is at optimum or
target level
II. Balancing exertion
with physical abilities
• Compare subjective exercise capacity
score with objective score
• Ask about five most problematic
activities (PSC) and score these
on the Borg RPE scale (6–20);
possibly score anxiety and/or
angina and/or dyspnoea
At start and end of CR and / or
training program, but also
continuous evaluation to check
for excessive strain
Patient (and partner) coping effectively with
symptoms, that is, patient avoids excessive
strain and (if possible) improves exercise
capacity (goal one). Patient is able to spread
his/her energy expenditure and to deal with
the dyspnoea in a functional way
III. Reducing fatigue,
dyspnoea and inactivity
• Borg RPE scale (6–20) for
fatigue and dyspnoea
• Monitor Movement and Health
(www.tno.nl) (in Dutch)
At start and end of CR and / or
training program
Patient’s sensation of fatigue and dyspnoea is at
optimum or target level. Patient has adopted
a physically active lifestyle
General physical goals
1. Exploring one’s
own physical limits
• Ask for five most problematic
activities (PSC)
• Ask patient to carry out problematic
activities and possibly score them for
duration and quality, perceived fatigue
(Borg RPE 6–20) and in terms of anxiety
and / or Angina and / or Dyspnoea
(if indicated).
• Monitoring heart rate and blood
pressure
At start and end of CR and / or
training program
Patient is aware of his/her own physical limits,
i.e. knows what level of exertion is possible
2. Learning to cope
with physical limitations
Monitoring heart rate, measuring
blood pressure and scoring on
Borg scale before, during and
after each session
Patient can cope with physical limitations and
utilise his/her limited energy efficiently, and
has achieved a balance between exertion and
relaxation
3. Overcoming fear
of physical exertion
• History-taking and observation
• Questionnaire: see
Multidisciplinary Guideline CR
2011 (www.nvvc.nl) (in Dutch)
At start and end of CR and / or
training program
Patient is no longer afraid of exertion
4. Developing an
active lifestyle
• History-taking (motivational interviewing)
• Monitor Movement and Health
(www.tno.nl) (in Dutch)
• Post-CR activities started
At start and at end of CR and / or
training program
Patient has adopted an active lifestyle or is
able to keep up the most active achievable
lifestyle
Focal points
Acquiring information
about secondary
prevention
• Checklist for risk factors / unhealthy behaviour
• Phase III activities started
• Ability to cope effectively with symptoms
• Ability to recognise signs of decompensation
At start and at end of rehabilitation
and / or training program
Patient knows about healthy living and
secondary prevention
Goals of relaxation program • Evaluation list
• Using a flowchart
At interim and final evaluation of
CR and / or relaxation program
Patient is familiar with the relaxation
program and is able to relax
Borg RPE scale Borg Rating of Perceived Exertion, KVL-H Dutch quality of life questionnaire for heart patients, 6MWT 6-min walking test, MET
metabolic equivalent of task, PSC Patient-specific complaints, SAS Specific activity scale, SWT Shuttle walk test, CR cardiac rehabilitation
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resistance of 60–70 % of Pimax for 4–5 times 5–10 min/day,
3–4 days a week, preferably 10 consecutive weeks, using a
threshold device.
Relaxation program
Recommendation 5. Relaxation therapy
A relaxation program (including breathing therapy) is recom-
mended in CHF patients. A relaxation program can lead to
tranquillity (a more quiet / less stressful mind), better breath-
ing control (more regular breathing), reduced sensation of
dyspnoea and an improvement of QoL (stress reduction)
(Level 2) [38–48].
A relaxation program in combination with aerobic training
is superior to training alone (Level 3) [40].
The CHF patient should attend two sessions to try
out the relaxation program. If the program proves ben-
eficial, they attend a further 6–8 sessions lasting 60–
90 min each. An important goal of the relaxation pro-
gram is to teach the patient to calm their mind and to
breathe more slowly. In addition, the program may
address cognitive themes such as understanding the
value of rest, the balance between work and rest, the
influence of psychological factors on physical function-
ing and differentiating between cardiac factors in rela-
tion to stress, anger, depression and pressure of time.
Instructions for relaxation can be given during exercis-
ing (active relaxation) or at rest (passive relaxation),
partly in the context of warming up and cooling down,
and partly as a separate relaxation program.
Evaluation
In addition to a ‘continuous’ evaluation over the entire course
of the training program, more comprehensive interim evalua-
tions should be carried out at least every 4 weeks, as well as at
the end of the CR program. Final evaluation criteria that may
prevail are listed in Table 5.
Table 6 shows the intended outcomes for the CR goals, the
relaxation program and patients’ acquired knowledge about
CHF and lifestyle, as well as recommendations for assessment
and evaluation.
The physiotherapist should report to the multidisci-
plinary CR team about the treatment process, the treat-
ment outcomes and the recommendations (aftercare).
This should happen at least at the end of the treatment,
but preferably also during the treatment period. In ad-
dition, the physiotherapist informs the patient’s cardiol-
ogist, family physician and, if applicable, their rehabil-
itation physician or company doctor.
Post-CR phase (phase III)
Recommendation 6. Continuation of a physically active
lifestyle
Patients are recommended to continue exercise, as part of an
active lifestyle, for the rest of their lives after the outpatient CR
period has ended, at a physiotherapy practice, at a certified
exercise facility or independently (Level 1–2) [49–51].
Monitoring by secondary care professionals to check if
CHF patients maintain their exercise capacity and an active
lifestyle in order to identify relapses at an early stage and
intervene is advisable (Level 3) [52].
Patients with an indication to attend high-intensity mainte-
nance training (≥60 % VO2 peak) should be referred to a
physiotherapy practice or a certified exercise facility (regis-
tered with the Dutch cardiac association), where professional
supervision is available. Patients should preferably continue
their training activities in a setting that participates in a local
network which includes the hospital or rehabilitation centre
where the CR program took place, as this implies easy access
and frequent contacts. Patients requiring low- or moderate-
intensity maintenance training (<60 % of VO2 peak) can
choose to do this independently, or at a certified exercise
facility. If patients who are advised to attend low- to
moderate-intensity maintenance training are deemed likely
to soon relapse into an inactive lifestyle, they should be
referred to a training program at a primary care physiotherapy
practice, under professional supervision.
Applicability and implementation issues
This guideline outlines best practice standards for physiotherapy,
in terms of efficacy, efficiency and tailored care, for CHF patients
who are eligible for CR. Implementation of the guideline in
clinical practice needs further evaluation. [53] Adherence to the
guideline needs to be stimulated by, for example, adopting it into
a decision supporting system/ flowchart, for example the Dutch
clinical algorithm for patient needs in CR [22].
Conclusion
Strong evidence is found for exercise-based CR in CHF patients,
especially for aerobic exercise training (endurance, interval and
HIT) during the outpatient rehabilitation, [4–6] and adopting
training after supervised CR. [49–51] It can be assumed that
treatment of pulmonary symptoms during the stay at the ICU/
CCU (if necessary) and earlymobilisation in the clinical phase (if
applicable) leads to a faster recovery, [20, 21] and also that
strength training, [5, 34] inspiration muscle training (in case
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impairment) [35–37] and a relaxation program [38–48] are ef-
fective in increasing Qol and exercise capacity, particularly in
combination with aerobic exercise training.
This guideline is the first guideline for physiotherapists that
provides practical guidance on how to tailor an exercise training
programwith respect to intensity and duration individually, using
results of a maximum or symptom-limited exercise test with
respiratory gas analysis. This guideline and also the guideline
for exercise-based CR in patients with coronary artery disease
[15] aims to reduce the considerable practice variation which has
recently been reported in Dutch CR centres, [7] and thereby, to
increase quality of exercise-based CR in the Netherlands [54].
Further research is needed on strategies to improve moni-
toring and follow-up of the maintenance of a physically active
lifestyle after supervised CR; for example by implementing
activity monitoring devices combined with telemonitoring, or
by web-based coaching platforms to guide patients. [55]
Exercise-based CR may also be followed by relatively brief
maintenance programs and booster sessions, including behav-
ioural techniques and focusing on incorporating lifestyle
changes into daily life, in order to improve long-term adher-
ence to lifestyle modifications. [56] Finally, more research is
needed into characteristics and modalities of physical activity
and exercise training in CHF in the long term.
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